The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis

키워드

참고문헌 (23)

1. Elzib H, "Antidepressant pharmacotherapy and poststroke motor rehabilitation : a review of neurophysiologic mechanisms and clinical relevance", Brain Circ, 5, pp.62~67 (2019)
2. Chollet F, "Fluoxetine for motor recovery after acute ischaemic stroke(FLAME) : a randomised placebo-controlled trial", Lancet Neurol, 10, pp.123~130 (2011)
3. Mikami K, "Effect of antidepressants on the course of disability following stroke", Am J Geriatr Psychiatry, 19, pp.1007~1015 (2011)
4. FOCUS Trial Collaboration, "Effects of fluoxetine on functional outcomes after acute stroke(FOCUS) : a pragmatic, doubleblind, randomised, controlled trial", Lancet, 393, pp.265~274 (2019)
5. D’Anci KE, "Treatments for poststroke motor deficits and mood disorders: a systematic review for the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense guidelines for stroke rehabilitation", Ann Intern Med, 171, pp.906~915 (2019)
6. Legg LA, "Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery", Cochrane Database Syst Rev, 2019, pp.CD009286~ (2019)
7. Beck AT, "An inventory for measuring depression", Arch Gen Psychiatry, 4, pp.561~571 (1961)
8. Jo SA, "Usefulness of Beck Depression Inventory(BDI)in the Korean elderly population", Int J Geriatr Psychiatry, 22, pp.218~223 (2007)
9. Shin MS, "The cut-off score for the Korean version of beck depression inventory", Korean J Clin Psychol, 12, pp.71~81 (1993)
10. Folstein MF, "“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
11. Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatry, 139, pp.1136~1139 (1982)
12. van Swieten JC, "Interobserver agreement for the assessment of handicap in stroke patients", Stroke, 19, pp.604~607 (1988)
13. Granger CV, "Stroke rehabilitation : analysis of repeated Barthel index measures", Arch Phys Med Rehabil, 60, pp.14~17 (1979)
14. Berg KO, "Measuring balance in the elderly : validation of an instrument", Can J Public Health, 83(Suppl 2), pp.S7~S11 (1992)
15. Sulter G, "Use of the Barthel index and modified Rankin scale in acute stroke trials", Stroke, 30, pp.1538~1541 (1999)
16. Mojtabai R, "Increase in antidepressant medication in the US adult population between 1990 and 2003", Psychother Psychosom, 77, pp.83~92 (2008)
17. Park GY, "The association between the severity of poststroke depression and clinical outcomes after first-onset stroke in Korean patients", Gen Hosp Psychiatry, 37, pp.245~250 (2015)
18. 박근영, "The Association between Post-Stroke Depression and the Activities of Daily Living", Gait Balance in Patients with First-Onset Stroke Patients, 2016, pp.13(6), 659~664[DOI]
19. Citrome L, "W When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed", Int J Clin Pract, 67, pp.407~411 (2013)
20. Ketter TA, "Treatments for bipolar disorder : can number needed to treat", harm help inform clinical decisions, 2011, pp.123, 175~189
21. Changsu Han, "The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study", Clinical Psychopharmacology and Neuroscience, 17(4), pp.495~502 (2019), 대한정신약물학회[DOI]
22. Changsu Han, "A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial", Clinical Psychopharmacology and Neuroscience, 16(4), pp.469~480 (2018), 대한정신약물학회[DOI]
23. Alessandro Serretti, "The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants", Clinical Psychopharmacology and Neuroscience, 16(1), pp.1~6 (2018), 대한정신약물학회[DOI]

관련 논문AI추천